Deirdre Egan

1.2k total citations
26 papers, 955 citations indexed

About

Deirdre Egan is a scholar working on Infectious Diseases, Pediatrics, Perinatology and Child Health and Virology. According to data from OpenAlex, Deirdre Egan has authored 26 papers receiving a total of 955 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Infectious Diseases, 11 papers in Pediatrics, Perinatology and Child Health and 9 papers in Virology. Recurrent topics in Deirdre Egan's work include HIV/AIDS drug development and treatment (19 papers), Pharmacological Effects and Toxicity Studies (10 papers) and HIV Research and Treatment (9 papers). Deirdre Egan is often cited by papers focused on HIV/AIDS drug development and treatment (19 papers), Pharmacological Effects and Toxicity Studies (10 papers) and HIV Research and Treatment (9 papers). Deirdre Egan collaborates with scholars based in United Kingdom, South Africa and Nigeria. Deirdre Egan's co-authors include Andrew Owen, David Back, Saye Khoo, Marta Boffito, Laura Else, Judit Morelló, Pablo Labarga, Gema González‐Pardo, Lorena Cuenca‐Bermejo and Sonia Rodríguez‐Nóvoa and has published in prestigious journals such as The Journal of Immunology, Clinical Infectious Diseases and Antimicrobial Agents and Chemotherapy.

In The Last Decade

Deirdre Egan

26 papers receiving 944 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Deirdre Egan United Kingdom	15	730	356	223	199	199	26	955
SH Khoo United Kingdom	15	614 0.8×	275 0.8×	166 0.7×	117 0.6×	200 1.0×	40	843
Caroline Solas France	23	920 1.3×	430 1.2×	162 0.7×	208 1.0×	258 1.3×	94	1.5k
Kristel M. L. Crommentuyn Netherlands	16	661 0.9×	334 0.9×	246 1.1×	208 1.0×	154 0.8×	21	864
Gregory E. Chittick United States	15	484 0.7×	287 0.8×	116 0.5×	127 0.6×	198 1.0×	18	798
Concepta Merry Ireland	18	780 1.1×	411 1.2×	187 0.8×	71 0.4×	216 1.1×	29	1.1k
Natsuo Tachikawa Japan	16	533 0.7×	217 0.6×	66 0.3×	240 1.2×	284 1.4×	74	999
Agnes I. Veldkamp Netherlands	17	697 1.0×	510 1.4×	140 0.6×	61 0.3×	185 0.9×	27	943
Angela Colbers Netherlands	20	630 0.9×	125 0.4×	243 1.1×	85 0.4×	231 1.2×	75	1.0k
Geoffrey J. Yuen United States	22	1.0k 1.4×	629 1.8×	246 1.1×	152 0.8×	416 2.1×	39	1.5k
P. L. Meenhorst Netherlands	19	682 0.9×	355 1.0×	134 0.6×	127 0.6×	261 1.3×	37	1.1k

Countries citing papers authored by Deirdre Egan

Since Specialization

Citations

This map shows the geographic impact of Deirdre Egan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Deirdre Egan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Deirdre Egan more than expected).

Fields of papers citing papers by Deirdre Egan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Deirdre Egan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Deirdre Egan. The network helps show where Deirdre Egan may publish in the future.

Co-authorship network of co-authors of Deirdre Egan

This figure shows the co-authorship network connecting the top 25 collaborators of Deirdre Egan. A scholar is included among the top collaborators of Deirdre Egan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Deirdre Egan. Deirdre Egan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Herrera, Carolina, Julianne Lwanga, Ming Lee, et al.. (2021). Pharmacokinetic/pharmacodynamic investigation of raltegravir with or without lamivudine in the context of HIV-1 pre-exposure prophylaxis (PrEP). Journal of Antimicrobial Chemotherapy. 76(8). 2129–2136. 9 indexed citations

Severino, Carol, et al.. (2020). International Undergraduates' Perceptions of their Second Language Writing Development and Their Implications for Writing Center Tutors. The Writing center journal. 38(1). 1 indexed citations

Zvada, Simbarashe, Paolo Denti, Mark Hatherill, et al.. (2019). A Population Pharmacokinetic Analysis Shows that Arylacetamide Deacetylase (AADAC) Gene Polymorphism and HIV Infection Affect the Exposure of Rifapentine. Antimicrobial Agents and Chemotherapy. 63(4). 20 indexed citations

Penchala, Sujan Dilly, Alieu Amara, Deirdre Egan, et al.. (2018). Validation and Clinical Application of a Novel LC–MS Method for Quantification of Dolutegravir in Breast Milk. Bioanalysis. 10(23). 1933–1945. 4 indexed citations

Sloan, Derek J., Alessandro Schipani, Deirdre Egan, et al.. (2017). Genetic Determinants of the Pharmacokinetic Variability of Rifampin in Malawian Adults with Pulmonary Tuberculosis. Antimicrobial Agents and Chemotherapy. 61(7). 34 indexed citations

Penchala, Sujan Dilly, Laura Else, Deirdre Egan, et al.. (2016). The development and application of a novel LC–MS/MS method for the measurement of Dolutegravir, Elvitegravir and Cobicistat in human plasma. Journal of Chromatography B. 1027. 174–180. 29 indexed citations

Liptrott, Neill J., Deirdre Egan, Andrew Owen, et al.. (2016). Cytotoxic chemotherapy and the evolution of cellular and viral resistance to antiretroviral therapy in HIV- infected individuals with lymphoma. HIV Clinical Trials. 17(5). 197–203. 1 indexed citations

Hennig, Stefanie, Tarylee Reddy, Deirdre Egan, et al.. (2015). Effect of SLCO1B1 Polymorphisms on Rifabutin Pharmacokinetics in African HIV-Infected Patients with Tuberculosis. Antimicrobial Agents and Chemotherapy. 60(1). 617–620. 10 indexed citations

Dickinson, Laura, Janaki Amin, Laura Else, et al.. (2015). Pharmacokinetic and Pharmacodynamic Comparison of Once‐Daily Efavirenz (400 mg vs. 600 mg) in Treatment‐Naïve HIV‐Infected Patients: Results of the ENCORE1 Study. Clinical Pharmacology & Therapeutics. 98(4). 406–416. 59 indexed citations

10.

Dickinson, Laura, Janaki Amin, Laura Else, et al.. (2015). Comprehensive Pharmacokinetic, Pharmacodynamic and Pharmacogenetic Evaluation of Once-Daily Efavirenz 400 and 600 mg in Treatment-Naïve HIV-Infected Patients at 96 Weeks: Results of the ENCORE1 Study. Clinical Pharmacokinetics. 55(7). 861–873. 38 indexed citations

11.

Olagunju, Adeniyi, Alessandro Schipani, Marco Siccardi, et al.. (2014). CYP3A4*22 (c.522-191 C>T; rs35599367) is associated with lopinavir pharmacokinetics in HIV-positive adults. Pharmacogenetics and Genomics. 24(9). 459–463. 20 indexed citations

12.

Jackson, Akil, Laura Else, Pedro M. M. Mesquita, et al.. (2014). A Compartmental Pharmacokinetic Evaluation of Long-Acting Rilpivirine in HIV-Negative Volunteers for Pre-Exposure Prophylaxis. Clinical Pharmacology & Therapeutics. 96(3). 314–323. 89 indexed citations

13.

Schipani, Alessandro, Deirdre Egan, Laura Dickinson, et al.. (2012). Estimation of the Effect of Slco1B1 Polymorphisms on Lopinavir Plasma Concentration in HIV-Infected Adults. Antiviral Therapy. 17(5). 861–868. 21 indexed citations

14.

Liptrott, Neill J., Deirdre Egan, David Back, & Andrew Owen. (2011). IFN-γ 874A>T Genotype Is Associated With Higher CCR5 Expression in Peripheral Blood Mononuclear Cells From HIV+ Patients. JAIDS Journal of Acquired Immune Deficiency Syndromes. 58(5). 442–445. 3 indexed citations

15.

Hartkoorn, Ruben C., Neill J. Liptrott, Deirdre Egan, et al.. (2010). HIV protease inhibitors are substrates for OATP1A2, OATP1B1 and OATP1B3 and lopinavir plasma concentrations are influenced by SLCO1B1 polymorphisms. Pharmacogenetics and Genomics. 20(2). 112–120. 138 indexed citations

16.

Owen, Andrew, et al.. (2010). Impact of CYP2B6 and CYP2A6 polymorphisms on efavirenz plasma concentrations in Ghanaian HIV‐infected patients. Journal of the International AIDS Society. 13(S4). 1 indexed citations

17.

Rodríguez‐Nóvoa, Sonia, Pablo Labarga, Vincent Soriano, et al.. (2009). Predictors of Kidney Tubular Dysfunction in HIV‐Infected Patients Treated with Tenofovir: A Pharmacogenetic Study. Clinical Infectious Diseases. 48(11). e108–e116. 194 indexed citations

18.

Nair, D.R., Colette Smith, Deirdre Egan, et al.. (2009). The Relationships of ABCB1 3435C>T and CYP2B6 516G>T With High-Density Lipoprotein Cholesterol in HIV-Infected Patients Receiving Efavirenz. Clinical Pharmacology & Therapeutics. 86(2). 204–211. 8 indexed citations

19.

Smith, Colette, Faye Turner, Deirdre Egan, et al.. (2009). Cytochrome P450 2B6 516G→T is associated with plasma concentrations of nevirapine at both 200 mg twice daily and 400 mg once daily in an ethnically diverse population. HIV Medicine. 10(5). 310–317. 54 indexed citations

20.

Dumortier, Hélène, Geertje J. D. van Mierlo, Deirdre Egan, et al.. (2005). Antigen Presentation by an Immature Myeloid Dendritic Cell Line Does Not Cause CTL Deletion In Vivo, but Generates CD8+ Central Memory-Like T Cells That Can Be Rescued for Full Effector Function. The Journal of Immunology. 175(2). 855–863. 35 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact